Noah Franklin is a highly accomplished and high-achieving Senior Scientist at Pfizer, widely regarded as one of the top emerging leaders in immunology and inflammation research. With nearly a decade of outstanding contributions to biomedical science, Noah has built an exceptional track record in early-stage drug discovery, novel target identification and validation, and translational research.
Noah brings elite-level expertise in CRISPR-based functional genomics, advanced multi-color flow cytometry, in vivo pharmacology, AI-assisted multiomics analysis, and complex primary cell-based assay development. A published researcher in the prestigious journal PAIN, Noah demonstrates the rare ability to drive multi-target therapeutic programs from initial concept through in vivo proof of concept.
Recognized early in his career with the Excellence in Research Award, Noah is known for outstanding scientific rigor, strong cross-functional leadership in highly matrixed environments, and dedicated mentorship of the next generation of scientists. His unique combination of deep immunology expertise, cutting-edge technical skills, and strategic scientific vision makes him an exceptionally strong candidate for senior research and leadership roles in biotechnology and pharmaceutical R&D.
Core competencies: immunology, inflammation, autoimmune disease, drug discovery, biologics, large molecule therapeutics, target identification, target validation, preclinical research, translational science, CRISPR, flow cytometry, in vivo models, multiomics, computational biology, immunohistochemistry, immunofluorescence, confocal microscopy, cell culture, ELISA, ELISpot, RT-qPCR, western blot, lentiviral transduction, 3D imaging, high-throughput screening.
